Purchases of Single Use Theatre Protective Clothing
A Contract Award Notice
by COLLABORATIVE PROCUREMENT PARTNERSHIP LLP
- Source
- Contracts Finder
- Type
- Contract (Products)
- Duration
- 1 year
- Value
- £12M
- Sector
- HEALTH
- Published
- 16 Jun 2021
- Delivery
- 01 Apr 2020 to 06 Apr 2021
- Deadline
- 25 Mar 2020 00:00
Concepts
Location
1 buyer
1 supplier
- Unisurge Newmarket
Description
Collaborative Procurement Partnership LLP (CPP LLP) acting on behalf of Supply Chain Coordination Ltd. Supply Chain Coordination Limited (SCCL) is a company Registered in England and Wales, with company number 10881715, Registered office address: Skipton House, 80 London Road, London, United Kingdom. [the 'Authority'] has awarded a contract for Unisurge International Limited to meet the urgent demand for PPE across the NHS and public sector as a result of the Corona Virus pandemic. The contract award is broken down by value into the following product category areas: Eye protection - £10,940,586.67 Face Masks - £241.75 Gowns - £583,258.47 Headwear - £2,063.83
Award Detail
1 | Unisurge (Newmarket)
|
CPV Codes
- 33199000 - Medical clothing
Indicators
- Contract is suitable for SMEs.
Other Information
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below • Extreme urgency brought about by events unforeseeable for the contracting authority and in accordance with the strict conditions stated in the directive Explanation: 1. The Coronavirus disease (COVID-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The COVID-19 outbreak is a Public Health Emergency of International Concerns as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020, by this stage Europe was the centre of the pandemic. 2. The use of Personal Protective Equipment (PPE) is critical in safeguarding the health and lives of the healthcare professionals treating patients with COVID-19. Delays in procuring the PPE, poses a risk to life of those on the front line and the likelihood of significantly increased death toll. 3. In March the NHS experienced severe shortages of PPE, modelling based the trajectory of other European countries forecast the need for significant and extremely rapid increase in the UK PPE capacity. Similar shortfalls in PPE stocks were identified globally. There was immense demand for PPE, requiring the need to actively seek and create new supply chains rapidly to meet that demand. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was impossible. PPE manufacturers and supply chains were under immediate and unprecedented global pressure to provide products. A delay in engaging with the market by running a usual procurement process ran the risk of failing to acquire the necessary stock of PPE equipment and presenting a significant risk to life. Collaborative Procurement Partnership LLP (CPP LLP) acting on behalf of Supply Chain Coordination Ltd (SCCL) is content the tests permitting use of the Negotiated procedure without prior publication are met: 1 The purchasing of PPE was identified as strictly necessary to meet anticipated demand. 2 It is responding to COVID-19 immediately because of public health risks presenting a genuine emergency. 3 The events that led to the need for extreme urgency were unforeseeable: The Commission itself confirmed: "The current coronavirus crisis presents an extreme and unforeseeable urgency - precisely for such a situation our European rules enable public buyers to buy within a matter of days, even hours, if necessary." 4 There was no time to run an accelerated procurement under the open, restricted or competitive procedures with negotiation that would secure products within the required timescales. 5 The situation is not attributable to the contracting authority: It has not done anything to cause or contribute to the need for extreme urgency.
Reference
- 2021/S 112-295658 - Unisurge International Limited
- CF 60627c3f-f5b2-4d95-bfa6-168c099148a6